StemCell Therapy

Join us for Personalized Medicine 9.0: Gene Therapy & Genome Editing This changes everything! Thursday 26 May 2016 8:00 a.m. to 6:00 p.m. An exciting topic every year South San Francisco Conference Center Personalized medicine seeks to use genetic variation to develop new diagnostic tests and treatments and to identify the sub-groups of patients for whom they will work best. This approach can also help determine which groups of patients are more prone to developing some diseases and, ideally, help with the selection of lifestyle changes and/or treatments that can delay onset of disease or reduce its impact. This year, in our ninth annual conference on personalized medicine, we address the promise of technologies like genome editing for gene therapy and drug discovery. The correction of genetic disease has been elusive until very recently, but the process of genome editing through the CRISPR/Cas9 system has revolutionized the field with unprecedented speed, and unparalleled opportunities. CRISPR has also proved to be one of the most powerful tools in basic genetics and biology developed in the last century, and provides new ways to understand cellular function. Using this knowledge, we have the potential to create pharmaceuticals and diagnostic tests with a speed and accuracy never before imagined. We explore the science behind gene therapy and genome editing, the realization of new diagnostic tools and treatments, the ethics of germline gene manipulation, and the implications for the future of the pharmaceutical industry and the human species. For further information or to sponsor this event, email us at dnamed@sfsu.edu Personalized Medicine The Time is Now We are happy to accommodate persons with special access requirements. Please contact Mike Goldman at: goldman@sfsu.edu or 415.338.1549

Read the original post:
Personalized Medicine SFSU

This entry was posted on August 4, 2016 at 9:36 am and is filed under Personalized Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |